Realtime Device-Driven Escalation-Avoidance for Heart Failure

Coredio provides a highly accurate, non-invasive intra-cardiac monitoring SaaS application to improve cardiac patient outcomes. The results aid cardiologists in progress tracking and medication titration, dramatically reducing unplanned admissions and readmissions.

Read more

Product Features

Coredio helps doctors, cardiologists and patients

Realtime Device-Driven Escalation Avoidance for Heart Failure

Coredio provides a highly accurate, non-invasive cardiac monitoring SaaS application to improve cardiac patient outcomes. The results aid cardiologists in progress tracking and medication titration, dramatically reducing unplanned admissions and readmissions.

Read more

Product Features

Coredio helps doctors, cardiologists and patients

Workflow

About The Platform

Personalized Cardiovascular Monitoring with CoreDio

Patient Eligibility: CoreDio is visioned to be prescribed by a cardiologist for patients with cardiovascular conditions such as heart failure upon their initial visit.

One-Time Calibration Process: A 20 minutes non-invasive one-time calibration is performed, leveraging the patient’s PPG, ECG, and portable ultrasound.
Once calibrated, CoreDio’s precision remains tailored to the individual patient for a subsequent up to 3 years.

On-Demand Monitoring: After one-time calibration, Cardiologists and HF nurses can use Coredio platform to seamlessly connect with PPG+ECG and cuff BP devices to monitor patient’s intra-cardiac BP, central BP and cardiac output (CO). The platform’s allows for monitoring within clinical settings or at-home.

See Demo
Contact Us
Workflow

About The Platform

Personalized Cardiovascular Monitoring with CoreDio

Patient Eligibility: CoreDio is visioned to be prescribed by a cardiologist for patients with cardiovascular conditions such as heart failure upon their initial visit.

One-Time Calibration Process: A 20 minutes non-invasive one-time calibration is performed, leveraging the patient’s PPG, ECG, and portable ultrasound.
Once calibrated, CoreDio’s precision remains tailored to the individual patient for a subsequent up to 3 years.

On-Demand Monitoring: After one-time calibration, Cardiologists and HF nurses can use Coredio platform to seamlessly connect with PPG+ECG and cuff BP devices to monitor patient’s intra-cardiac BP, central BP and cardiac output (CO). The platform’s allows for monitoring within clinical settings or at-home.

See Demo
Contact Us

How It Works

In order to manage patient medication post-discharge, cardiologists and HF nurses need to monitor Intra-cardiac pressure, Cardiac Output (CO), and Central BP.

1-time calibration: At the initial visit, the doctor connects patient to routine checkup tools and uses Coredio’s platform to make it patient-specific.

Read More
Contact Us

How It Works

In order to manage patient medication post-discharge, cardiologists and HF nurses need to monitor Intra-cardiac pressure, Cardiac Output (CO), and Central BP.

1-time calibration: At the initial visit, the doctor connects patient to routine checkup tools and uses Coredio’s platform to make it patient-specific.

Read More
Contact Us

Accuracy

The Sensitivity Of The Device In Finding Accurate Statistics

Accuracy & Validation

  • Validation: Tested at partner hospitals
  • Standard Comparison: Strong correlation with arterial line BP and echo-based CO
  • Patient Trials: Studies ongoing at multiple sites

Future Milestones:

  • Regulatory: FDA advisory team is preparing for FDA pre-submission.
  • Expansion: Kicked-off 2 internal review board (IRB) approved studies.

Precision

CoreDio’s technology features:

  • Intra-cardiac pressure monitoring (in validation)
  • On-demand CO/CBP trends across week days
  • Deviation of less than 5mmHg for Central BP
  • Deviation of less than 5% for CO

AI helps it get even better

Accuracy

The Sensitivity Of The Device In Finding Accurate Statistics

Accuracy & Validation

  • Validation: Tested at partner hospitals
  • Standard Comparison: Strong correlation with arterial line BP and echo-based CO
  • Patient Trials: Studies ongoing at multiple sites

Future Milestones:

  • Regulatory: FDA advisory team is preparing for FDA pre-submission.
  • Expansion: Kicked-off 2 internal review board (IRB) approved studies.

Property Accuracy

CoreDio’s technology features:

  • Intra-cardiac pressure monitoring (in validation)
  • On-demand CO/CBP trends across week days
  • Deviation of less than 5mmHg for Central BP
  • Deviation of less than 5% for CO

Testimonials

Testimonials from patients and doctors

See More

Cardiologist #1

Head of Cardiology (EP)

By potentially averting re-admission hospitalizations, it not only ensures better patient care but also can result in significant savings – approximately $20k per instance.

Cardiologist #2

Heart Failure Specialist

Noninvasive measurement of intra-cardiac pressures can elevate our remote patient monitoring programs, by enabling guideline-directed medication therapy for HF patients.

Cardiologist #3

General Adult Cardiologist

In our high-volume cardiac clinic, where we perform >100 caths daily, the immediate value of CoreDio platform is undeniable. We’d integrate it without hesitation if available.

Partners